2 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
Follow Kind Pharmaceuticals LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) AND017, ESA - Anemia Due to Chronic Kidney Disease | Phase 3 | Recruiting | Kind Pharmaceuticals LLC | 240 | 2025-12-03 | 2026-03-27 |
| A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia AND017 capsules, ESA - Anemia Due to Chronic Kidney Disease | Phase 3 | Recruiting | Kind Pharmaceuticals LLC | 300 | 2025-10-31 | 2026-03-27 |
Anemia (2)
China (2)